Iopamidol (18 brand names, 1 dosage form, 1 route)
Available dosage forms: INJECTABLE.
Routes of administration: INJECTION.
Brand Names
- IOPAMIDOL
- IOPAMIDOL-200
- IOPAMIDOL-200 IN PLASTIC CONTAINER
- IOPAMIDOL-250
- IOPAMIDOL-250 IN PLASTIC CONTAINER
- IOPAMIDOL-300
- IOPAMIDOL-300 IN PLASTIC CONTAINER
- IOPAMIDOL-370
- IOPAMIDOL-370 IN PLASTIC CONTAINER
- ISOVUE-128
- ISOVUE-200
- ISOVUE-250
- ISOVUE-300
- ISOVUE-370
- ISOVUE-M 200
- ISOVUE-M 300
- SCANLUX-300
- SCANLUX-370
Boxed Warning
Intrathecal administration of ISOVUE, even if inadvertent, can cause death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema [see Warnings and Precautions (5.1)]. ISOVUE Imaging Bulk Package is for intra-arterial or intravenous use only [see Dosage and Administration (2.2, 2.3, 2.4)].
Contraindications
None.
Adverse Reactions
The following adverse reactions are described in greater detail in elsewhere in the labeling: Risks Associated with Intrathecal Administration [see Warnings and Precautions (5.1)] Hypersensitivity Reactions [see Warnings and Precautions (5.2)] Acute Kidney Injury [see Warnings and Precautions (5.3)] Cardiovascular Adverse Reactions [see Warnings and Precautions (5.4)] Thromboembolic Events [see Warnings and Precautions (5.5)] Extravasation and Injection Site Reactions [see Warnings and Precautions (5.6)] Thyroid Dysfunction in Pediatric Patients 0 to 3 Years of Age [see Warnings and Precautions (5.8)] Severe Cutaneous Adverse Reactions [see Warnings and Precautions (5.11)]
Overdosage
The manifestations of overdosage are life-threatening and affect mainly the pulmonary and cardiovascular systems. Treatment of an overdose is directed toward support of all vital functions and the prompt institution of symptomatic therapy. Iopamidol can be removed by dialysis.